Etoposide-d4
Etoposide-d4 (VP-16-d4; VP-16-213-d4) is the deuterium labeled Etoposide. Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy[1].
Product Specifications
Product Name Alternative
VP-16-d4; VP-16-213-d4
UNSPSC
12352005
Target
Antibiotic; Apoptosis; Autophagy; Bacterial; Isotope-Labeled Compounds; Mitophagy; Topoisomerase
Related Pathways
Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Others
Field of Research
Cancer
Smiles
OC1=C(C=C(C=C1OC)[C@H]2[C@H]3C(OC[C@@H]3[C@@H](C4=C2C=C5C(OCO5)=C4)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)CO[C@@](C([2H])([2H])[2H])(O7)[2H])O)O)=O)OC
Molecular Formula
C29H28D4O13
Molecular Weight
592.58
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1254536-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus Heme response regulator hssR (hssR)
Sign In for Pricing
View Details MBS1254536-02 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus Heme response regulator hssR (hssR)
Sign In for Pricing
View Details